1. Home
  2. OGN vs DSL Comparison

OGN vs DSL Comparison

Compare OGN & DSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.75

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo DoubleLine Income Solutions Fund of Beneficial Interests

DSL

DoubleLine Income Solutions Fund of Beneficial Interests

N/A

Current Price

$10.66

Market Cap

1.2B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
OGN
DSL
Founded
1923
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
OGN
DSL
Price
$13.75
$10.66
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$11.40
N/A
AVG Volume (30 Days)
2.6M
503.2K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
0.60%
11.95%
EPS Growth
N/A
N/A
EPS
0.95
N/A
Revenue
$6,216,000,000.00
N/A
Revenue This Year
$0.45
N/A
Revenue Next Year
$1.67
N/A
P/E Ratio
$14.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.69
$10.49
52 Week High
$13.76
$12.67

Technical Indicators

Market Signals
Indicator
OGN
DSL
Relative Strength Index (RSI) 72.40 43.13
Support Level $13.46 $10.53
Resistance Level N/A $11.02
Average True Range (ATR) 0.04 0.11
MACD 0.00 -0.01
Stochastic Oscillator 93.18 18.04

Price Performance

Historical Comparison
OGN
DSL

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About DSL DoubleLine Income Solutions Fund of Beneficial Interests

DoubleLine Income Solutions Fund is a closed-end management investment company. Its primary investment objective is to seek high income and its secondary objective is to seek capital appreciation. It invests in debt securities and other income-producing investments anywhere in the world, including emerging markets. The company's investment portfolio comprises foreign corporate bonds, U.S. corporate bonds, bank loans, collateralized loan obligations, non-agency commercial mortgage backed obligations, asset-backed obligations, and municipal bonds among others.

Share on Social Networks: